Search
for
Sort by
Research 571–600 of 1000+
- 567 Acute generalized exanthematous pustulosis (AGEP) induced by plaquenil
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Metabolic syndrome and dermatological diseases: association and treatment
- Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction?
- Mechanisms of autophagy and their implications in dermatological disorders
- Vulvovaginal involvement in Netherton syndrome: A case report
- The therapeutic efficacy of mesenchymal stem cells and their extracellular vesicles in the treatment of diverse skin diseases
- Premature hair graying: a multifaceted phenomenon
- Pathogenesis of Chemical Leukoderma and Chemical‐Induced Vitiligo
- Exosomes: Historical Evolution and Emerging Roles in Dermatology
- Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
- Unlocking the therapeutic potential of TRPV3: Insights into thermosensation, channel modulation, and skin homeostasis involving TRPV3
- LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor
- A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23
- 0951 Breezula, a clinical stage topical anti-androgen, promotes dermal papilla inductivity and reduces IL-6 secretion in balding skin samples ex vivo
- Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Anti-ageing effect of a lactococcal strain: analysis using senescence-accelerated mice
- Treatment of Alopecia Areata with Anti-Interferon-γ Antibodies
- Anti-inflammatory and anti-hyperplastic effect of Bazhengsan in a male rat model of chronic nonbacterial prostatitis
- Investigation of the Gene Expression Levels of 5 α-reductase, VEGF and IL-1α in HaCaT Cells after the Application of a Botanical Extract
- Comprehensive Evaluationof Tectonagrandis L.f.: Integrated <i>In Vitro</i> and <i>In Silico</i> Analysis of Steroid 5α-ReductaseInhibition and Anti-Inflammatory Properties
- Melatonin Exerts Prominent, Differential Epidermal and Dermal Anti-Aging Properties in Aged Human Eyelid Skin Ex Vivo
- The Anti-atopic Lotions Containing Fucoidan Extracted from Ecklonia Cava Impact on Hairless Mice Atopic Dermatitis Skin